Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
2. No 1886
3. No-1886
1. 133208-93-2
2. No-1886
3. Lipoprotein Lipase Activator
4. Opf 009
5. Opf-009
6. Diethyl (4-((4-bromo-2-cyanophenyl)carbamoyl)benzyl)phosphonate
7. Phosphonic Acid, ((4-(((4-bromo-2-cyanophenyl)amino)carbonyl)phenyl)methyl)-, Diethyl Ester
8. Phosphonic Acid, [[4-[[(4-bromo-2-cyanophenyl)amino]carbonyl]phenyl]methyl]-, Diethyl Ester
9. Diethyl 4-((4-bromo-2-cyanophenyl)carbamoyl)benzylphosphonate
10. 07h1561618
11. Diethyl 4-[(4-bromo-2-cyanoanilino)carbonyl]benzylphosphonate
12. Diethyl 4-[(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate
13. Ibrolipim [usan:inn]
14. 4-diethoxyphosphorylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
15. No 1886
16. Ibrolipim [usan]
17. Unii-07h1561618
18. Ibrolipim [inn]
19. N-(4-bromo-2-cyanophenyl)-4-(diethoxyphosphorylmethyl)benzamide
20. Ibrolipim (usan/inn)
21. Mls006011667
22. Chembl34234
23. Schembl493918
24. Dtxsid20157989
25. Zinc1552570
26. Akos005067076
27. Ss-3273
28. Ncgc00481428-01
29. Smr002529695
30. Hy-117549
31. Cs-0066427
32. D03747
33. D83803
34. J-006332
35. Q5984863
36. 4-diethoxyphosphinoylmethyl-n-(4-bromo-2-cyanophenyl)benzamide
37. Diethyl4-((4-bromo-2-cyanophenyl)carbamoyl)benzylphosphonate
38. Diethyl (4-((4-bromo-2-cyanophenyl)carbamoyl)benzyl)phosphonate
39. Diethyl 4-[n-(4-bromo-2-cyanophenyl)carbamoyl]benzylphosphonate
| Molecular Weight | 451.2 g/mol |
|---|---|
| Molecular Formula | C19H20BrN2O4P |
| XLogP3 | 3.5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 8 |
| Exact Mass | 450.03441 g/mol |
| Monoisotopic Mass | 450.03441 g/mol |
| Topological Polar Surface Area | 88.4 Ų |
| Heavy Atom Count | 27 |
| Formal Charge | 0 |
| Complexity | 576 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Hypolipidemic Agents
Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)
Lipoprotein Lipase Activators
Compounds that increase the enzymatic activity of LIPOPROTEIN LIPASE. Lipoprotein lipase activators have a potential role in the treatment of OBESITY by increasing LIPID METABOLISM. Note that substances that increase the synthesis of lipoprotein lipase are not included here. (See all compounds classified as Lipoprotein Lipase Activators.)
Ibrolipim has known human metabolites that include [4-[(4-Bromo-2-cyanophenyl)carbamoyl]phenyl]methyl-ethoxyphosphinic acid.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
We have 1 companies offering Lipoprotein Lipase Activator
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
Market Place
